IPO Trending
GLANDSME / NSE, BSEListed

Gland Pharma Limited

Founded in Hyderabad, India, in 1978, Gland Pharma has evolved from a small-scale contract manufacturer to one of the largest and fastest-growing injectable-focused companies. It has a global presence in 60 countries, including the United States, Europe, Canada, Australia, and India. Operating primarily under a B2B model, Gland Pharma has a strong track record in developing, manufacturing, and marketing complex injectables. Its integrated presence across the value chain has fueled rapid growth. The company is promoted by Shanghai Fosun Pharma, a leading global pharmaceutical company.

₹1,490 - ₹1,500Open
Listed Price1710.00
Listing Gain+14.00%
FinancialsBalance sheet and operational figures in Crores
Metric Breakdown

Revenue

Latest (June-20)9162.89 Cr
Growth-45.2%
Revenue Trend (₹ in Crores)
0.010.6k21.3k31.9kMar-18Mar-19Mar-20June-20
PeriodRev (Cr)PAT (Cr)AssetsDebt
June-209,162.893,135.9046,912.650
Mar-2027,724.087,728.5840,860.390
Mar-1921,297.674,518.5635,235.490
Mar-1816,716.823,210.5129,294.680